Screener
Lexicon Pharmaceuticals LXRX Business Segments — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 39 | 33 | 147 | 63 |
| Research and development, including stock-based compensation of $1,384, $1,620, $2,753, and $3,194 respectively | 17,443 | 15,747 | 30,199 | 31,050 |
| Selling, general and administrative, including stock-based compensation of $1,952, $1,575, $3,661, and $3,044 respectively | 9,750 | 9,350 | 18,984 | 20,958 |
| Total operating expenses | 27,232 | 25,130 | 49,330 | 52,071 |
| (Loss) income from operations | (26,540) | 3,736 | (27,536) | (21,943) |
| Interest and other expense | (2,609) | (2,318) | (4,199) | (4,153) |
| Interest and other income | 1,723 | 1,834 | 3,266 | 4,053 |
| Loss on early extinguishment of debt | (4,349) | — | (4,349) | — |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's business segments — total costs & expenses?
- Lexicon Pharmaceuticals (LXRX) reported business segments — total costs & expenses of $27.23M in Q2 2026.
- How has Lexicon Pharmaceuticals's business segments — total costs & expenses changed year-over-year?
- Lexicon Pharmaceuticals's business segments — total costs & expenses increased by 8.4% year-over-year, from $25.13M to $27.23M.
- What is the long-term trend for Lexicon Pharmaceuticals's business segments — total costs & expenses?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's business segments — total costs & expenses has grown at a -0.7% compound annual growth rate (CAGR), from $100.9M to $98.71M.
- What does business segments — total costs & expenses mean?
- The aggregate of all operating costs incurred by the business segment, including cost of sales, R&D, and administrative overhead. This metric provides a comprehensive view of the total capital required to sustain the segment's operations. Comparing this to segment revenue reveals the overall cost structure and operational sustainability.
Ask your AI about Lexicon Pharmaceuticals's business segments — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude